Alaunos Therapeutic Banner Image

Alaunos Therapeutic

  • Ticker TCRT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Alaunos Therapeutic Logo Image
  • 11-50 Employees
  • Based in Houston, Texas
Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With their robust and innovative discovery engine, they strike cancer at its core by engineering cell therapies that target neoantigens arising from genomic mutations. They have developed proprietary, rapid, cost-effective solutions to deliver tumor-specificMore killer T cells to large cancer patient populations with unmet clinical need. They are based in Houston, TX, home to the largest medical center in the world; and in a state with no state income tax and a low cost of living.
4.8 / 5.0 (176)

Alaunos Therapeutic reports have an aggregate usefulness score of 4.8 based on 176 reviews.

Alaunos Therapeutic

Most Recent Annual Report

Alaunos Therapeutic
MOST RECENT 2023 Annual Report and Form 10K

Alaunos Therapeutic does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Alaunos Therapeutic Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!